Recurring guests Saurabh Jha, MD, radiologist in Philadelphia, and Vinay Prasad, MD, MPH, hematologist/oncologist in San Francisco, seek to settle the debate surrounding COVID vaccine passports. Both scholars defend their recently published viewpoints – Dr. Jha arguing for passport mandates and Dr. Prasad arguing against them. Will requiring proof of vaccination be driven by the business sector, local or federal governments, or anywhere in between? Will vaccines help jump-start or continue to stall economies? When is the right time to impose a vaccine passport, if ever at all? This is a real barn-burner of a discussion that you won’t want to miss.
View Dr. Jha’s publication on The Health Care Blog: https://thehealthcareblog.com/blog/2021/04/29/the-market-forces-behind-vaccine-passports/
View Dr. Prasad’s publication in Medscape: https://www.medpagetoday.com/blogs/vinay-prasad/92107
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
